The clinical effects of plasma exchange and high dose intravenous immunoglobulin (IVIg) were evaluated in a 41 year old woman with Isaacs' syndrome. After double filtration plasma exchange, symptoms almost disappeared for two to three weeks and the recorded continuous muscle action potentials were considerably decreased. Symptoms recurred within a few months. On the other hand, IVIg worsened the symptoms of the disorder: during and after IVIg at a dose of 0-2 glkg/day (total 50 g), widespread myokymia, pseudomyotonia, and muscle cramps gradually increased. Symptoms improved after another course of plasma exchange.
Isaacs' syndrome is a rare disorder characterised by muscle stiffness, impaired relaxation after contraction (pseudomyotonia), and generalised myokymia.' 2 The cause of the disorder is still obscure, but previous reports have suggested that an immune mechanism may be involved.36 Plasma exchange has reduced pseudomyotonia in the disorder.56 High dose intravenous immunoglobulin (IVIg) has been used successfully to treat Guillain-Barre syndrome7 and other presumably immunological disorders affecting peripheral nerve8 or muscle. 9 We evaluated the effects of plasma exchange and IVIg in a patient with Isaacs' Informed consent concerning all tions and treatments was obtained patient beforehand.
Double filtration plasma excha performed with PVA (Plasmacure, Japan) as the first filter and Ev; (Kuraray, Japan) as the second. exchange was carried out three tim alternate day schedule. The total ar plasma processed was 5X58 litres. Si improved two days after completing session of plasma exchange. The de frequency of resting myokymia al decreased. She was unable to rel hand grip before the last session, days after the session the grip rele was 3*3 seconds, which further deci 1-3 seconds after seven days.
Two (fig 2) . symptoms deteriorated to pretreatm( about two months after double plasma exchange.
About five months after double plasma exchange, immunoglobulin globin-I, Midorijyuji, Japan) was giv venously at a dose of 0-2 g/kg per d 50 g) for five consecutive days. Th experienced general fatigue two days start of IVIg. Dysphagia increased three and dyspnoea appeared on de EMG study showed an increase in 
